Mistrust and bias are key barriers to realizing the potential of AI in healthcare but addressing the accuracy and economy of large language models can help.
This white paper by the World Economic Forum, written in collaboration with ZS, highlights the most promising use cases for patient-facing generative AI solutions, their biggest barriers ...
Antimicrobial resistance is known as a quiet pandemic but more data, investment, policy incentives and a holistic approach via One Health could defeat it.
The global health and economic burden of obesity must be addressed with policy action for prevention, evidence-based practice and access to treatment.
A new report offers several ways we can transform our food systems and encourage nutritious choices. Watch the video to learn more.
In the US alone, a drug-resistant bug called MRSA infects 80,000 people every year and kills more than 10,000. Researchers at MIT used a ‘deep learning’ AI to search for new antibiotics. ...
To increase the success of drug trials and improve medical treatments, pharma companies must effectively harness AI, says Thomas Clozel, CEO @OwkinScience.
Under-resourced and over-burdened, too many health systems are struggling to address the changing burdens of disease driven by a rise in chronic conditions and worsened by the devastating...
Life insurance companies have much to gain from their policyholders' extended, healthier lives. AI can help the industry play a more active role in fostering preventative health.
Health systems globally face numerous challenges and their capacity to handle them depends greatly on the quality of their governance.
While glucagon-like peptide 1 agonists (GLP-1) have been identified as an effective weight-loss drug, they should only be part of the solution.
Discover how generative AI can transform global healthcare by creating end-to-end solutions that bridge the divide between documentation and outcomes.









